Best Professional Sales Aid

Share this article:
Best Professional Sales Aid
Best Professional Sales Aid

Recognizes excellence in the promotion of drugs, devices, diagnostics and other medical services via sales aids distributed directly to healthcare professionals.

GOLD AWARD
Health 4 Brands and Savient ­Pharmaceuticals
Krystexxa Sales Aid

This sales aid impressed judges on several levels. One praised it for telling a “compelling story,” while another complimented its impactful graphics.

“Great flow,” said a third. “Each page stands on its own.”

Krystexxa, a new treatment for refractory chronic gout (RCG), is delivered via intravenous infusion and works differently than standard treatments to lower uric acid levels. Health 4 Brands explained that the market had been dominated by one class for more than 40 years, and patients who were unresponsive or unable to take the standard treatment had no other options.

Doctors were either unaware of Krystexxa or skeptical of the need for infusion therapy. The agency was charged with establishing Krystexxa as the most innovative option to provide clinical and emotional benefits for gout patients.

The aid covers clinical and emotional aspects well. An x-ray of a foot showing the result of RCG is balanced by an image of baby feet stepping onto adult feet with the headline “The Next Step is Krystexxa.”

“For those familiar with the intense pain of a flare, bearing the weight of a child on the affected joint is simply not an option, as even a bed sheet is intolerable,” the agency noted. “Rheumatologists were drawn to the emotionality the foot-on-foot image evoked and appreciated the balance of it as a payoff to the clinical lead-in with the stylized x-ray.”

The agency said market research and anecdotal response from doctors revealed that the foot-on-foot image conveys the powerful transformation Krystexxa provides. The sales force reported high levels of physician engagement.

SILVER AWARD
ICC and Sunovion
The Right Fit

ICC was challenged to help drive adoption of nebulized LABA Brovana in treating COPD patients. “Nebulized LABA monotherapies are recent entries for treating COPD and don't yet occupy a defined and ownable place in this market,” the agency noted. The aid defines the appropriate Brovana patient, showing why it's right for the patient. The cover depicts the competitive landscape, and a spot-varnish techinque helps highlight Brovana as a comfortable treatment alternative. Clinical data reinforces messaging throughout.

THE FINALISTS

• Draftfcb Healthcare and ­Cephalon—Nuvigil Proud Sponsor

• Giant Creative/Strategy and Neutrogena—Sun Portfolio

• Health 4 Brands and Savient Pharmaceuticals—Krystexxa Sales Aid

• ICC and Sunovion—The Right Fit

• ICC and Sunovion—Critical Moment

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.